Fundraising Fox

GLYCANAGE Biological age testing

6 known investors

GlycanAge offers an at-home biological age test that analyzes IgG glycan patterns to measure chronic inflammation ("inflammaging") and its effect on aging. Customers use a finger-prick kit, receive a report on their glycan indexes and biological age, and get a 1:1 interpretation call with a specialist.

BiotechDigital HealthLongevity

Investors · 6

Exceptional VenturesLondon
Impetus CapitalSofia
South Central VenturesLjubljana · $1M – $2M
Velocity DigitalLagos
Vesna AdvisorsLuxembourg · $200K – $700K
LAUNCHub VenturesreportedSofia · $324K – $3.2M

Frequently asked questions

What does GLYCANAGE Biological age testing do?
GlycanAge offers an at-home biological age test that analyzes IgG glycan patterns to measure chronic inflammation ("inflammaging") and its effect on aging. Customers use a finger-prick kit, receive a report on their glycan indexes and biological age, and get a 1:1 interpretation call with a specialist.
Who are GLYCANAGE Biological age testing's investors?
GLYCANAGE Biological age testing's investors include Exceptional Ventures, Impetus Capital, South Central Ventures, Velocity Digital, Vesna Advisors, LAUNCHub Ventures.